Genetic mutations in key redox regulators, such as tumor protein p53 (TP53) and kelch-like ECH-associated protein 1 (KEAP1), profoundly affect redox homeostasis, tumor progression, and therapeutic resistance. This evidence concerns the gene KEAP1 and neoplasm.